Syntax Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,254
Closed -$213K 198
2023
Q2
$213K Sell
2,254
-604
-21% -$51K 0.17% 181
2023
Q1
$216K Buy
2,858
+219
+8% +$16.5K 0.16% 195
2022
Q4
$203K Sell
2,639
-483
-15% -$36.7K 0.17% 191
2022
Q3
$208K Sell
3,122
-696
-18% -$44.1K 0.18% 176
2022
Q2
$200K Buy
3,818
+105
+3% +$5.97K 0.17% 194
2022
Q1
$211K Sell
3,713
-845
-19% -$45.3K 0.18% 195
2021
Q4
$235K Buy
+4,558
New +$224K 0.17% 191

Other funds holding CAH

Syntax Advisors's CAH Position: Q3 2023 in Review

Syntax Advisors sold out of Cardinal Health (CAH) in Q3 2023, closing a stake of 2,254 shares — an estimated $213K sold.

Syntax Advisors first reported a position in CAH in Q4 2021 and held it in 7 quarters. The position peaked at $235K in Q4 2021. 948 funds tracked by Wall St. Rank hold CAH as of Q3 2023.

  • Syntax Advisors reported no remaining Cardinal Health position as of Q3 2023 after selling out during the quarter.
  • Syntax Advisors sold 2,254 Cardinal Health shares in Q3 2023, an estimated $213K.
  • Syntax Advisors first reported a position in Cardinal Health in Q4 2021 and held it in 7 quarters.
  • Syntax Advisors's Cardinal Health position peaked at $235K in Q4 2021.
  • 948 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.